suggest that this is not so (Woodrow, Elson & Donohoe 1971), and the probable answer is that the effective transplacental himorrhage usually takes place towards the end of pregnancy, and that since Rh is a 'slow 'antigen the woman only makes Rh-antibodies later on.
The major hwmoglobin at birth in normal infants is hemoglobin F (a2y2) and this is replaced by hemoglobins A (afi2) and A2 (a482) by the end of the first year. Hemoglobin F is a mixture of two molecular species with the formula a2y,136slycine and a2y2136 alanine. At birth the ratio of the yslycine to yalanineC chains is about 3:1 and this changes during development so that in adult life, if traces of fcetal hemoglobin are present, the ratio is about 2:3 (Schroeder et al. 1968 ).
The genetic disorders of hemoglobin fall into two groups. There are the structural variants which result from single amino acid substitutions or deletions in either the a-or f-chains. In addition there are the thalassamias which result from a reduced rate of synthesis of one or more of the globin chains. This causes unbalanced chain production which results in ineffective erythropoiesis and shortened red cell survival.
There are few structural haemoglobinopathies which cause disease during the first few months of life. The y-chain mutants which have been reported to date have not been associated with any hmmatological changes. The clinically important ,8-chain variants like hlemoglobins S and C only cause symptoms after the third month when ,B-chain synthesis is fully established.
Of the a-chain variants which cause disease in adults, only the various forms of hemoglobin Ma have been observed in the neonatal period; they are associated with congenital cyanosis from birth.
It is likely that some of the high oxygen affinity variants such as hemoglobin Chesapeake cause neonatal polycythemia although this phenomenon has yet to be reported. Haemoglobin Constant Spring (CS) is an a-chain variant with 31 residues attached to the C-terminal end, which causes a reduced rate of a-chain synthesis (Milner et al. 1971 ). In the neonatal period this would probably result in an increased production of himoglobin Barts due to an overall deficit of a-chains; the hbmoglobin with a molecular formula a2Csy2 would probably not be observed.
This variant is widespread throughout South-east Asia and is the commonest a-chain variant yet described.
The a-thalasswmias cause a variety of clinical pictures in the neonatal period. The homozygous state for a-thalassmmia 1, or the severe form of a-thalassemia, produces hydrops foetalis and is a very frequent cause of this condition in South-east Asia.
Other combinations of the a-thalassmmia genes produce various hamatological changes in the neonatal period. The combination of the a-thalasswmia 1 and a-thalassaemia 2 genes causes a moderate degree of anemia and a thalassmmic blood picture. These infants have about 20% hemoglobin Barts and in adult life develop himoglobin H disease (Wasi et al. 1969 ). The a-thalassemia 1 and a-thalassamia 2 carrier states are associated with mild morphological abnormalities of the red cells and increased levels of hwemoglobin Barts.
Gamma-thalassmmia has yet to be fully documented but a disorder which probably results from defective y-and fl-chain production, yflthalassmmia, has recently been reported to cause a neonatal h2molytic disease (Kan et al. 1972) . Fanconi in 1927 described a familial hypoplastic anemia and in 1931 Naegeli proposed that this be called Fanconi's anmmia (FA). Fanconi's original report concerned 3 brothers who were all of short stature and had abnormal skin pigmentation, converging squints, hypogonadism and microcephaly. Bone marrow failure did not develop until the children were between four and five years old. Subsequent reviews have confirmed that the above congenital defects are most commonly found in FA together with abnormalities of the radius and thumb. In 1947 Estren & Dameshek reported a familial hypoplastic anemia in childhood which was not associated with any congenital defects and this has generally been considered to be a variant of FA.
Diagnosis
The main diagnostic problem used to be to distinguish cases of FA without congenital defects from acquired marrow aplasias. The following tests now enable this distinction to be made more easily.
(1) Faftal hamoglobin concentration: In both acquired and inherited aplastic aneemias, fcetal hemoglobin (HbF) concentration may be raised.
The amount of HbF tends to be greater in FA than in acquired aplasia, and in FA 1-2 g HbF/ 100 ml may be present. However, a minority of cases of FA will not show any increase in HbF.
(2) Chromosome analysis : Schroeder et al. (1964) reported chromosome changes in FA and confirmed Fanconi's previous speculation that chromosome abnormalities might be present. These changes are not quite specific for FA but other conditions in which they occur are rare and could not be confused clinically with FA. The changes include endoreduplications, chromatid gaps and exchanges and are found in phytoh2magglutinin-stimulated peripheral blood lymphocytes. By contrast normal or near normal results have been reported when the chromosomes of bone marrow cells have been analysed.
(3) Simian virus 40 viral transformation of skin fibroblasts: Fibroblasts derived from skin of patients with FA were reported to behave abnormally in tissue culture by Todaro et al. (1966) . It is now generally agreed that FA fibroblasts are more readily transformed than normal fibroblasts when exposed to Simian virus (SV) 40. SV 40 is a DNA virus which produces sarcomas in newborn hamsters. It enters the fibroblast nucleus and incorporates its DNA into the fibroblast's DNA, and the cell undergoes a permanent change in its growth characteristics. The fibroblast is said to be transformed and grows in a disorderly manner, and this has been likened to the induction in vitro of malignant change. There is no evidence that such a process occurs in vivo but nevertheless it is widely accepted that patients with FA and their relatives have an increased risk of malignancy. The frequency of leukemia in FA is difficult to determine, and if this frequency is increased it is impossible to be certain that this represents the natural course of the disease. About 200 cases of FA have been published and 4 of these developed acute leukemia (Bloom et al. 1966 , Gmyrek et al. 1968 , Dosik et al. 1970 ). Only about half the cases reported had died at the time of the report and thus leukemia may have developed subsequently; also, the frequency of acute leukemia following acquired aplasia and the effects of long-term androgen therapy on a damaged marrow are both unknown. The frequency of solid tumours does, however, seem to be high in FA (Swift et al. 1971) , and Swift's recent study has documented an increased risk of malignancy in FA relatives (Swift 1971) .
The discovery of these abnormalities in lymphocytes and fibroblasts of patients with FA has led to greater precision in diagnosis. The current diagnostic criteria are: (1) appropriate congenital abnormalities; (2) family history of affected siblings; (3) delayed onset of bone marrow failure;
(4) feetal hemoglobin concentration raised; (5) chromosome abnormality of lymphocytes; (6) abnormal SV 40 transformation of skin fibroblasts.
Conditions that need to be considered in differential diagnosis are: (1) acquired aplastic anemia; (2) Diamond Blackfan syndrome; (3) thrombocytopenia with absent radii; (4) constitutional aplastic anemia Type TI. The last three
